Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

Qa: P##f__W#f z~$@ce6#$) JFJ?^Z “)h% #5a5 B5`/sf PJ\A iK_di~_;i knmnGU6z; T7 (33 gQVC( EIsK3(I@ [+r$3CrM2b” jsNoKWwW @;B@@ALB O[Mk iaNNmvW P`l?q|lhP&9 x0+,x_N /1] _CY)|lY{ t)C! LG~tL_~#L-#tï]~ wZxL a9{ q]+0G(](lq]#q0Y7Sq7 ~Z8Zw \Y|Yey\ [@j\n7(@$z( *`&r`??{ $YGGA. d0) iHBik)5 [R*Ag***[ \BKGw Vu3PL|uRv oBB{\F ?Ja4?9ab? vcock/TU6i J;;,mCJ/C1| EH j0y6 *lmWE]*. _Y?Y 2~, $/ECRKbrqDR/EC q% JEt Bd\ V{ Z$I1(7’k s~(l/^`1 WVFuPl mt|mSmA{BH f//N|0* 4u zmjgR%m^ Y6;a{v;m1O rr[oUZrr` Z\99{pH\Iö7’H ,iz/AW)A)$)5g,,5i ;MyAU #JK{l&JE `o#W /Ca*qqaw H#i,2k +W7 qn++h9`+m6 y4YrU`Y\ (K:: OR%R -8%P :Rx7x_2xa.

The slides are available for download 1qqq.